Epstein-Barr Virus miR-BART6-3p Inhibits the RIG-I Pathway
Yuanjun Lu(East China University of Science and Technology), Jian Ma(Central South University), Xiang Zheng(Novo Nordisk Foundation), Lingyu Wei(East China University of Science and Technology), Jianhong Lu, Chunlin Ou(Central South University), Zailong Qin(Guangxi Maternal and Child Health Hospital), Ying Zheng(Central South University), Guiyuan Li(Xuzhou Medical College), Xuemei Zhang(Weifang Medical University), Wei Xiong, Jia Wang(Shantou University), Peng Qiu(Central South University), Qiurong Ye(Central South University), Yuxin Fu(Qufu Normal University), Qun Yan(Central South University)
Cited by 122
Related Papers
S100A8/A9 in Inflammation
|Frontiers in Immunology|2018|1.5k
Circular RNAs function as ceRNAs to regulate and control human cancer progression
|Molecular Cancer|2018|1.1k
Neoantigen vaccine: an emerging tumor immunotherapy
|Molecular Cancer|2019|718
Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles for Systemic Delivery of RNAi Therapeutics
|Molecular Therapy|2013|624
Regulatory mechanisms of PD-1/PD-L1 in cancers
|Molecular Cancer|2024|619